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Some studies have reported in vitro inactivation of
membrane enveloped viruses by Butylated hydroxy toluene (BHT).
This study investigates the effect of orally administered
BHT on primary infections of Herpes simplex virus (HSV)
using rabbit corneas as the assay system .
Assigned levels of BHT were incorporated into the diet
of New Zealand White rabbits infected with HSV-l McKrae
strain on the corneal surface of the eyes.

The degree of

infection was measured by a subjective assay.

Rabbits

rece iving BHT in their diet conSistently experienced lower
levels of infection.

The interpretation of this data is that

orally administered BHT can be an effective inhibitor of
primary infections by HSV in rabbits.
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INTRODUCTION AND LITERATURE REVIEW
Snipes, et al.. (1975) reported that the common food
additi ve butylated hydroxy toluene (BHT) could inactivate
lipid containing vi ruses including He r pes simpl ex virus
(HSV) in vitro.

Results of studie s by this same group,

Keit h, e t al., (1982)

showed BHT to be an effective

inhibitor of herpes cutaneous infections in mice when
applied topically.

Brugh (1977) demonstrated that dietary

BHT , widely used as an additive to poultry feed, was an
effective treatment for the protection of chickens exposed
to either virulent or avirulent strains of Newcastle disease
virus, also a membrane bound virus.

Kim, et al., (1978)

noted that BHT could inactivate cytomegalovirus and Semliki
Forest virus, both membrane bound viruses.
BHT is an antioxidant added to food that acts as a fat
stablizer , preventing spoilage caused by oxidation.

The

Food and Drug Administration (FDA) has approved the addition
of BHT to the human diet at a concentration of 0.02 percent
(200 ppm) by weight based on the fat or oil content of the

food (Handbook of Food Additives, 1972).

For people living

in the United Kingdom the level is 1 mg per day (Snipes,
et al., 1975).
Seventy-five percent of the daily intake of BHT is
excreted in the urine and feces during the first 24 hours
after ingestion in man with the remainder partitioning into
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the body ' s adipose tissue where it accumu lates to an average of 1. 30 ppm and 0.2 3 ppm in the Uni ted States and the

Unit ed Kingdom, respectively (Collings and Sharr at , 1970).
In vitro studies have s hown t hat the BHT concentratio n
necessary for antiviral activity of HSV corresponds to
approximately ten t imes this level of accumulation in human
adipose tissue (SnipL3, et al., 1975).

There is disagreement regarding the biological effects
that hi gh l eve ls of BHT can have on cells, organs and
organisms.

Studies invol v ing long-term administration of

BHT to mice showed hyperplasia of hepatic bile ducts (Clapp,
et al., 1973).

Early studies reported tera t ogenic abnor-

malities in rats (Brown, et al., 1959); subsequent experiments
showed no teratogenic lesions resulted from BRT administration
(Frawley, et al., 1965) .

Thus it was reported that BHT was

not a teratogenic a gent (Johnson, 1965).

Mice offspring

whose mothers had received a diet of 0 . 5\ BHT during
gestation demonstrated a fifty percent decrease in brain
cholinesterase activity (Stokes, et al., 1972).

DeRios ,

et al., (1978) reported that BHT protects against ultraviolet (UV)-induced skin erythema and was found to be
effective in reducing UV-induced carcinogenesis (Chan and
Black, 1977).

Gilbert and Golberg (1965) noted that BHT

can e licie hyperfunctional liver enlargement but without
histopathological evidence of hepatic damage.

Numerous

studies have found BHT to be noncarCinogenic, nonmutagenic,
and generally nontoxic (Keith, et al., 1982).

Probably of

3

most importance was t he long- term study by Allen (1976)
i ,n wh ich dosages of BHT 20 0 t.imes g r e ater than is permis-

sible in the human diet demonstrated no il l e ffects on
the he alth of adult fema le primates .

Also, no effect was

noted on e mbryon ic and feta l development r e sultin g from
long-term exposure of BHT to the mothers both p rior to
conception and d urin g gestation .

It has b een suggested that

the different effects e licited in primates and rodents may
b e a r e sult of differences in metabol i sm of BHT by these
orga nisms (Daniel, et al., 1968).
For a substance to be used as an antiviral compound it
must be effective and safe for those to whom i t is
administered.

Dietary leve ls of BHT of 0.5% by weight are

considered to be reasonably safe (Takahashi and Hiroga, 1978).
BHT appe ars to be an effective antiviral compound against
memrane-bound viruses.

The list of membrane bound virus e s

is too large to enumerate here but includes varicella-zoster
virus (chickenpox and shingles), Epstein-Barr virus (infectious mononucleosis and Burkitt's African lymyphoma),
ctyomegalovirus (ctyomegalic inclusion disease), and Herpes
simplex virus (herpes keratitis, herpes labialis, and herpes
p rogenitalis) .
Herpes keratitis is a

HSV infection of the c ornea l

and conjunctival epithelium of mammalian eyes.

There are

an es timated 300,000 cases of this disease per year in the
Un i ted States (Vision Research, US Department of Health,
Education, and Welfare, 1977), and it is the major cause of

4

blindness due t o co rn ea l infections (Gan garosa, et a 1. ,
1979 ) .

Primary infections can occur via direct contact of

HSV with the supe rficial tissues of the e ye or b y n e uroge nic
movement of HSV into the ophthalmic branch of the trigeminal
n e rve from th e trigeminal gan g lia (Kristensson, et a1.,
1971 ) .

Following subsidence of the primary infection, the

virus can reside in a quiescent

(la ~ent)

state until which

time recurrent infections may be elicited.

The site of this

latent state has bee n demonstrated to be the trigeminal
ganglia (Kwan, et a1. , 1981), but low levels of HSV have also
been found at the site of recurrence even when no corneal
lesions were present (Neshurn, et a1., 1972).

It has been

proposed that viral shedding in lacrimal and salivary glands
may be responsible for recurrent herpes infection (Kaufman,
et al., 1967).

Frequent recurrence of HSV infection can

cause irreversible damage to the corneal epithelium and
p ossibly cause deep stroma keratitis (Vision Research, US
Department of Health, Education and Welfare, 1977).
The purpose of this research was to investigate the
effect of orally administered BHT on rabbit corneas infected
with Herpes simplex virus.

The facility of observation of

lesions on the surface of the eye and the ability to induce
recurrent infections artificially make the rabbit eye an
effective model for studying the effects of this antiviral
agent on HSV infections.

This study includes investigations

of the effectiveness of BHT at different dosages, the timing
of administration for the most effective response and BHT's
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effectiveness on differe nt levels of vira l exposure.

MATERIALS AND METHODS
Rabbits

New Zealand White rabbits (Coccus doities) we re used
for all experiments.

Three week old animals we i ghing

approxima tely 0 .5-0 .75 kilograms were caged and allowed to
acclimate in the laboratory for a

~ riod

of four days.

The

rabbits were fed chow (Purina) and allowed to drink water
ad libitum .

The average daily food intake of each rabbit

was measured by weight over a three day period and recorded.
Treatment
A concentrated treatment solution of BHT was obtained
by dissolving a known quantity of BRT (Sigma Chemical Co.)
in 100\ ethanol (ETOH) by weight/volume.

The solution was

applied to one half the average daily food intake, by weight,
of the rabbits to be treated such that the food would be
coated with sufficient BHT to make up a known (assigned) percentage of the animals' daily food intake.

The food was

heated in an oven at 60·C to allow evaporation of the ETOH
from the treated chow, leaving the BRT on the food.

The

treated chow was then added to the rabbits' diet at the top
of the food bin in an effort to ensure its consumption first .
(Since this one half daily food intake was treated with the
entire daily dosage of BHT, a rabbit consuming its average
daily food intake consumed its daily dOBe of BHT.)

After

initiation, the BRT treatment continued for the entire course
of the experiment.
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Rabbits not receivin g BHT treatment we r e fed re g ular
chow.

In the fi rst t wo e x p eriments ETOH was added to t he

chow of non-trea ted rabbits and evapora ted off to de te rmine

if an afte rtaste of
an i mals.

ETOH

might affect the appetite of the

No change in appetite was o bs e r ved ; therefo r e,

ETCH was not added to the chow of non-treated rabbits in
experiment I I I and IV.

Virus
HSV-l McKrae strain was obtained from Dr. James Hill,
Medical College of Georgia in Augusta.

Initial samples were

propagated in primary rabbit kidney cells (PRK cells) and used
in experiments I

and II.

Viral samp le s propagated in

African g reen monkey cells (CVI-P cells) were used in
experiments I I I and IV.
CVJ-P cells were maintaine d in a growth medium consisting
of oelbecco Modified Eagle's medium with addition of 10\ fetal
calf serum (Microbiological Associates), 0.29 9 L-glutamine,
16 ml of 100X antimycotic antibiotic mixture (Gibco) per
litre medium and buffered to pH 7.2 with 0.3 g sodium bicarbonate.
inoculation .

Cells were incubate d at 37°C until the time of
The infected cells were incubated at 37°C for

four to f i ve days at which time the vi rally infected cells
began to falloff.

Viruses were harvested after incubation

and centrifuged at 200X g to obtain partially purified virus
and were stored in vials at a concentration of 10 7 plaque
f orming units (pfu) per ml at -70°C until used.

The number
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o f i nfectious virus ne c e ssary t o p r od uce a plaq ue ( are a of
cells destroyed) whe n inoculate d into c onf luent mono layers
of ce lls in vitro constituted a pfu.

Viral stocks were

diluted into Ca 2+ and Mg 2+ free phosphate buffered saline
(P BS) to obtain the titre desired fo r infection.
viral Inoculation
RAbbits wer e anesthetized in early experiments by
intraperitoneal (I P ) injections of sodium pentobarbital.
In later experiments, rabbits were placed in a glas8 chamber,
etherized and observed until they became sedate .
Fifty microlitres of a solution of HSV-l of sufficient
titre to cause a severe infection of the cornea was
administered, usin g a micropipette, to the surface of the
eye of animals to be infected.

The eye was carefully

massaged for one minute to allow ample spreading of infectious
virus throughout the superficial tissues of the rabbit eye.
Eye Readings
Lesions were usually visable in three to four days
post-inoculation .

Eyes were observed at five days and ten

days post-inoculation for Experiment I and two day intervals
after infection for at least ten days for Experiments II,
III, and IV.
Lesions were observed and quantitated in the following
manner: one drop of a fluorescein (Ayerst Labs) solution was
placed in the eye, the eye was massaged and the lid was then
pulled back and kept open during observation: the room lights
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we r e shut of f and th e eye illumi nated with t he output from
a I S-watt "bl a kli ght" lamp emi ttin g 97% o f its radiation
between 300 an d 400 nm.

These wave l eng ths c aused the

fluorescein t o fluoresce in the ye llow- green r egion of the
visible spe ctrum.

Corneal e pithe lial l e sions we r e observed

with the a id of a stereomicroscope (7.0X magnification)

and scored on a seve rity scale that ranged from 0 (no
lesions) to 6 (very heavy lesions).

In addition, the extent

of the corneal surface covered by lesions was measured using
a grid.

The product of the severity value of the daily

corneal lesion scores and the percent of the cornea covered
",'as termed the "daily response" (DR).

The sum of the daily

responses for each eye over the entire course of the measurements was termed the "integrated response" (IR).
Viral Shedding Assays
In order to ensure that the lesions observed were due
to HSV-l infection, eye fluid samples were routinely taken by
adding 0.1 ml of PBS to the corneal surface, closing the lid,
and gently massaging the eye.

After removal of 0.025 ml of

eye fluid, an assay was performed on CVI-P cells to verify
that the plaque development rate and plaque morphology was
s i mi l ar t o th at o f HSV-l McKrae s t r a in .
Experiment I
Rabbits one through four received no treatment with
BHT nor were they inoculated with HSV-l (control group).
~bits

five through eight were inoculated with HSV-l McKrae
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st r ai n of a titre of

6 xl O~

pfu (HSV g r oup) .

Rabb i ts nine

t h rough 12 we r e i noc ulated wi t h HSV-l Mc Krae stra in at the
afore mentioned titre and started r eceivi r.g a di e t of 0.5 \
BHT 2 days post-inoculation (HSV-BHT g roup) .

Rabbits 1 3

through 16 rece ived a diet of 0 . 5% BHT for three days before
bein g inoculated with HSV-l McKrae strain o f a titre
consistent with the above (BHT-HSV group) •
EXPeriment II

Rabbits 17 through 20 received no BHT nor were they
infected with virus.

Rabbits 21 through 24 were inoculated

with 7xlO~ pfu HSV-l HcKrae strain (HSV group).
through 28 were inoculated with

7xlO~

Rabbits 25

pfu HSV-l McKrae

strain and started receiving a diet of 1\ BHT two days
post inoculation (HSV-BHT group).

Rabbits 29 through 32

received a diet of 1% BHT for seven days prior to inoculation
with

7xlO~

pfu HSV-l McKrae strain (BHT-HSV group) •

Experiment III
Rabbits 33 and 34 received no BHT in their diet nor
were they inoculated with virus.

Rabbits 35 and 36 were

inoculated with 1.5xl0 6 pfu HSV-l (high virus titre) on both
the right and left eyes.
with

1.5 x lO~

Rabbits 37 and 38 were inoculated

pfu HSV-l (medium virus titre) on both eyes.

Rabbits 39 and 40 were inoculated with 1.5xl0 2 pfu HSV-l
(low virus titre) on both eyes .

Rabbits 41 and 42 received

a diet of 0.5' BHT for a period of five days prior to
inoculation with 1.5xl0 6 pfu HSV-l (BHT-high virus titre)
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on both e yes .

Rabbits 4 3, 44 an d 45 r ece ived a diet of

0 . 5 \ BHT for a period of five d ay s prior t o inoc ula t ion
wi th

1 .Sx lO ~

pf u HSV-l (BHT-med ium virus titr e ), rabbit

43 on both e y e s, rabbits 44 an d 45 on the ri ght e ye only.
Rabb i ts 46. 4 7 and 48 recei ve d a die t of 0.5 % SHT for a

pe r iod of five days pr io r to i noculati on with 1.5xl0 2 pfu
HSV-l (BHT-low virus titre ) , rabbit 46 being inoculate d
on both eyes and rabbits 47 and 48 being inoculated on the
ri ght eye only.
Experiment IV

Rabbits 49 through S2 were inoculated with 1.5 x l0 6
p £u HSV-l (HSV) .

Rabbits 53 through 56 received a diet of

0.001 % BHT for a per i od of fi ve days prior to inoculation
with 1 . 5xlO '

pfu HSV-l (0.001\ BHT-HSV).

Rabbits 57 through

60 received a diet of 1% BHT for a period of five days prior
to inoculation wi th 1. 5x l0 6 pfu HSV-1 (1 % BHT-HSV).

Rabbits

61 through 64 received a diet of 5% BHT for a period of five
days prior to inoculation with 1 . 5x l0 6 pfu HSV-l (5% BHTHSV) .

RESULTS
The d ata obtained f r om Expe riments I and II are shown
in Table I.

The data obtained from Experiments III and I V

are shown in Table II.

All data showed the same trend

whether reported as severity, ?ercent surface area of eye
covered, daily response or integrated response.

The average

"daily response" value was chosen as the neasure for comparing
results on the graphs and the "integrated response" value
was chosen as the measure for comparing results on the
tables .
Experiment I
Rabbits one through four , comprising the control group,
showed no signs of infection during the course of the
experiment.

The IR values for rabbits five through eight

(HSV) ranged from 1. 5 to 3.75 with an average of 2.36.

Rabbit

six died after one reading, therefore its IR is not included
in the range and mean values.

The IR values of rabbits nine

through 12 (HSV-BHT) ranged from 0.31 to 1.9 with an average
of 0.9 2 .

The IR values of rabbits 13 through 16 (BHT-HSV)

ranged from 0 . 2 to 1.0 wi th an average of 0.55 (Table I).
The graph in figure 1 indicates the average degree of viral
i nfe ction per group per reading.

The graph indicated BHT

to be inhibitive to the early development of primary HSV
lesions since in the first reading, taken five days postinoculation, the a ve rage IR of animals not receiving BHT

TABLE I
INTEG RATED RESPONSE EVALUATION

Sum of I R f o r

All Ey e s Infected

Number of
I n f ect e d Eyes

Ran ge of

Avera ge

IR

IR'S

Experiment I
Control
HSV*

HSV-SHT
SHT-SHT

0
7.09
3.66
2.2

4
4
4

0
1.5 -3 . 75
0.31-1.9
0.2 -1.0

0
2.36 ±1.23
0.92 ±0.74
0.55 ±0.39

0
16.49
6.67
0.89

4
4
4
3

0
0.23-7.1
0.4 -3.65
0.1 -0.4

0
4.12 ±3.07
1 .67±1. 47
0.30±0.17

3

Experirrent I I
Control

HSV
HSV-SHT
BHT-HSV*

*Rabbits 6 and 29 died during course of these experiments and therefore were
not included in the data of their respective groups.

...
w

TAB LE II

I NTEG RATED RESPONSE EVALUATI ON

Sum of IR for
All Eye s Infected

Number of
Infected Eyes

Range of

0
31. 57
10.04
14.42
2.49
6.06
0

2
4
4
4
2
4
4

0
2.53-16.3
0- 6.55
0.05- B.B7
1.04- 1.45
0- 3.2
0

0
7.B9 ' 5.97
2.51'2.99
3.6l±4.16
1.24±1.03
1.51±1.67

3.4
1. 06
1.7
3.3B

3
3

00.150.2 0.95-

1.13'1.24
O. 35±1. 71
0.43±0.32
1.13±0. B2

IR

Average
IRIS

Experiment II I
Control
l.5xl0 6 pfu
1.5xlO ~ pfu
l . 5xl0 2 pfu
BHT-l.5xl0 6 pfu
BHT-l.SxlO~ pfu
BHT-l.Sxl0 2 pfu

titre
titre
titre
titre*
titre
titre

OtO

Experiment IV
HSV*
1. 001\ BHT-HSV'
1\ BHT-HSV
5% BHT-HSV·

4
3

2.45
0.46
0.9
1.29

*Rabbits 44, 49, S3 and 63 died during the course of these experiments and
therefore were not included in the data of their respective groups.
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Fi g ure 1.

Results of Experiment I:

X

Comparison of severity

' eye surface with lesions of groups receiving

HS V inoculation, HSV inoculation with BHT

treatment beginning two days post-inoculation
and HSV inoculation with BHT treatment beginning
three days before inoculation.

w
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I
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Fig ure 2.

Results of Experiment II: Comparison of the
averag e daily response of groups receiving
HSV inoculation(.), HSV inoculation with BHT
treatment beginning two days post-inoculation
(A) and HSV inoculation with BHT treatment
beginning three days before inoculation (0).
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Fig ure 3.

Results of Experiment tIl : Comparison of the
ave rage daily response of groups a 10 6 pfu
viral inoculation ( . ) , a 10 6 pfu viral
inoc ulation with BHT treatment beginning five
days prior to inoculation ( D ), a 10 4 pfu viral
inocul" tion (. ), a 10'* pfu viral inoculation
with BHT treatment beg inning fi ve days prior
to inoculation (4), a 10 2 pfu viral inoculation
( . ) and a 10 2 pfu vi ral inoculation wi th BHT
treatment beginning five days prior to
inoculation ( 0 ) .
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Figure 4.

Results of Experiment IV:

Comparison Of average

daily response of groups receiving a 10 6 pfu

viral inoculation (46), a 10 6 pfu viral
inoculation with a 0.001\ diet of BHT beginning
five days prior to inoculation ((», a 10 6 pfu
viral inoculation with a 1\ diet of BHT
beginning five days prior to inoculation (a),
a 10 6 pfu viral inoculation with a 5\ diet of

BHT beginnin g five days prior to inoculation
(.4) •
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TABL E III
SUf-1MARY TABLE OF RABBITS- EXPE RIMENTS I AND II

Rabbit
Number

Infection
(pfu)

BHT

IR

Maximum
Severity

Inflammation

Death

1

No

No

0

0

No

Administered

2
3
4

No
No

No
No

0

0
0

No
No

Died 6-7-82

No
6 xl 0 it

No

0

No

5

Yes

6xlO it

No

6

No

,
6x10
,
6x10

No

3.75

6

Yes

No

5

Yes

0.5 %

1. 50
0.31

3

Yes

it

0 . 5%

0. 4

3

Yes

,

0. 5%

1.9

5

Yes

0.5 %

1. 05

5

No

0.5%

1.0

4

No

0.5%

0.2

4

No

0 . 5%

0.75

5

No

0 . 5%

0.25

3

No

5
6
7
8
9
10

11
12
13

14

15

6x10

,

6xlO
it
6xlO
6x10
6 xlO it
6xlO

it

,
6x10
,
6xlO

No

0
0
1. 84

Administered
Administered
Administered
Died 6-7-82
Administered
Administered
Administered
Administered
Administered
Administered
Administered
Admin i s te red
Administered

17

No

No

0

0

No

Administered
Administered

18

No

No

0

0

No

Administered

16

...

'"

TABLE I II

Rabbit
Number

Infection
(pfu)

(Continued)

Maximum
BHT

IR

Severi t y

Inflammation

Death

19

No

No

0

0

No

Administe red

20

No
7xl0

No

0

0

No

Administered

7.1
3. 18

6
6

Yes
Yes

Administered

7xIO "

No
No

23

7xlO "

No

5.98

6

Yes

Administered

24

7xlO lt

No

2

Yes

Admi n istered

25

7x1O "

1%

0.23
0.72

3

No

Administered

26

1%

0.4

3

No

Administered

27

7xIO "
7xIO"

1%

1.9

5

Yes

Administered

28

7xlO lt

1\

3.65

6

Yes

Administered

29

7xIO "

1%

2

No

30

7xIO "

1%

0.39

3

Yes

Administered

31
32

7xlO tt
7xlO'+

1\

0.4

Ye s

Administered

1%

0 .1

3
2

No

Administered

21
22

Administered

Died 0.0. Et her

'"

<:>

TABLE IV
SUMMARY TABLE OF RABBITS - EXPERIMENT III

Rabb it

Infection

Nurrber

(pfu)

33
34

No
No

35

1. 5xlO 6

36
37
38
39

41

Maximum
Severity

Inflammation

1. 5xlO it
l.5xlO lo

0
0
5.19
7.55
16.3
2.53
0.49
6.55

0
0
6
6
6
4
5
6

No
No
Yes
Yes
Yes
No
No
No

L 5xlO It
1. 5xlO "

No
No

0
3.0

0
6

No
No

1. 5xlO 2

No
No

8.87
0.05

6
1

Ye s
No

No
No
0.5\

5.0
0.5
0
0

6
5
6
5

No
No
Yes
No

1. 04
1. 45

3
5

No
No

1. 6x10 6
1. 5x1 0 '
1. 5x10 6

1.5x10'

1. 5xlO 2
1. 5xlO 6

1.5x10'
42

IR

No
No
No
No
No
No
No
No

1. 5x 10 '
40

BHT

1.5x10 '
1. 5x10 '

0.5\

Death
Administered
Administered

10-9-82
10-9-82
10-9-82
weak, favored
one eye

10-9-82
weak, facial
contortions

10-9-82
weak, facial
contortions

10-9-82
10-7-82
respiratory
problems
Administered
N

....

TABLE IV (Con t i nu ed)

Rabbit
Number

43

Infection
( p fu)

1. 5xlO 4

IR

0. 5\

3. 2

5

No

0.16

2

No

0
2.7

0
5

No
No

Administered
Administered

0
0
0

0
0
0
0

No
No
No

Administered

No

Administered

1. 5xlO 4

44

1. 5xlO 4

45

1.5xlO 4

46
47

1.5xlO 2
1. Sx10 2
1. 5xlO 2

48

1.5xlO 2

Maximum
Severity

BHT

0.5 \
0.5 \
0.5 \
0.5\
0.5\

0

Inflammation

De ath

10-7- 82
heart
puncturetaking blood

Administered

TABLE V
SUMMARY TA8LE OF RABBITS-EXPERIMENT IV·

Rabbit
Nuni>er

I nfection
IR

(pfu)

BHT

49

1. 5x10 .

No

50
51
52

1. 5x10 ·
1. 5x10 .

No
No

0
2.45

1. 5x10 ·

No

0.95

53

1.5x10 ·

0.001\

2.76

54

L5xlO 6

0.45

55

1.5x10 ·

0.001\
0.001\

56

1.5x10 ·

0.001\

~

57

1.5x10·

58

Maximum
Seve rity

Death
Died 2-3-83
Administered
Administered

0

. 41;

u
6
4
6
3
4
3

1\

0.90

(;

1. 5x10 .

1\

0.3

3

59

1.5x10·

1\

0.20

2

60

1. 5x10.

1\

0.30

2

61
62

1.5x10·

5%

0.95

6

2-21-83

1.5x10 ·

5%

1.14

6

2-14-83

63

1.5x10·

5%

0

2-10-83

64

1.5xlO ·

5%

4

2··22-83

·Inflammation was not observed.

0 . 45

0
1.29

Administered
Died 2-14-83

Administered
Administered
Admini s te red
A-iministered
Admird stered
Administered
Administered
Was not eating
Was not eating
Was not dating
Wa~ not eating

'"w
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was g reate r by a fac tor of s ix o r mo r e than the avera ge IRIs
of anima l s r e ceiving a BHT diet.

Th e s econ d r ead in g taken

ten day s post-inoc ulati o n i n di cate s the cours e of inf ec tion
to be decre asin g with the exception o f th e g roup wh ich

be g an a BUT d iet two days post-inocu lation (HSV-BHT).
Experl~nt

II

Rabbits 17 through 20 showed no signs of i nfection
during the course of the experiment (control group).

The IR

values of r&?bits 21 through 24 ranged from 0.23 to 7.1 with
an a ve rage of 4.12 (HSV group).
through 28

ran~ed

(HSV-BHT group).

from 0.4 to 3.65 with an average of 1.67
The IR v alues of rabbits 29 through 32

ranged from 0.1 to

group).

The IR values of rabbits 2S

~. 3

with an average of 0 .3

(BHT- HSV

Rabbit 29 died from an overdose of ether after two

readings. thus i ts I F. v a l ue was n ot includ e d in t he dete rmination of the
\ T~i~

I).

r ~ nge

and mean values o f the BHT-HSV group

The graph in figure 2 shows the course of

infection over eight days for the three groups that were
inoculated with the virus using average daily response values
per g roup as the criteria.

The daily response values peaked

at day six post-inoculation for the HSV group and the HSV-BHT
group, however, the infection for the group not receiving BHT
was three fold hi gher at day six .

The average daily response

v alue of the g roup receiving BHT seven days previous to
inoculation showed early inhibition of virus with some
increased infection by days six to eight post-inoculation.
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The daily re s ponse of the BHT- HSV g roup during t he cour s e of
the experiment i ndicated inhi bition of p r ima ry i n fection by
dieta ry BHT.

Expe riment I I I
Rabbits 3 3 an d 34 showed no sig n o f in fec tion throughout the cours e o f the expe rime n c .

The IR v alue s of the four

eyes inoculate d with a hi g h v i rus titre

(rabbits 35 and 36)

rang ed from 2 . 53 to 16.3 with an ave rage of 7.89.

The IR

values of the four eyes inoculated with a medium virus titre

(rabbits 37 and 38) ranged from 0 to 6.55 with an average of
2.51.

The IR values of the four eyes inoculated with a low

v irus titre (rabbits 39 and 40) ranged from 0.05 to 8.87 with
an ave rage o f 3. 6 1 .

The IR v alues of the BHT-high virus titre

g roup (rabbits 41 and 42) were obtained from two eyes.
Rabbit 41 died of r e spiratory problems during the course of
the experiment and was not considered in the data.

The IR

v alues of the two inoculated eyes of rabbit 42 had a range

o f 1.04 to 1.45 with an average of 1.24 .

The IR values of

the f our inoculated eyes of rabbits 43, 44 and 45 (BHTme dium virus titre group) ranged from 0 to 3 . 2 with an
avera ge of 1.51.

The four inoculated eyes of rabbits 46 , 47

and 48 (BHT-1ow v irus titre group) showed no signs of
in fe ct i on throughout the course of the experiment (Table II) .
All animals inoculated with HSV-I McKrae strain not fed a
0.5 \

diet of BHT died within 14 days post-inoculation.

g raph in fi g ure 3 depicts the average daily response

The
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indicat i ng t he c o u rs e of th e in f ection per g roup.

Al l

groups ino c ul ated wi th H5V-l Mc Kr ae strai n and not fed
dietary BHT s howed h ig her avera ge daily re s pons e value s than
BNT f e d g ro ups of the c orre s pondi ng vi ral tit re s.

Expe riment IV

The I R values f o r rabbits 49 through 52 ran ge d from 0
to 2.45 wi th an a v erage of 1.13.

The IR values f or rabbits

53 th r ough 56 (0.001 \ BHT-H5V) ran ge d from 0.15 to 0.46 with
an average o f 0 . 43.

The IR values of rabbits 61 throu gh 64 (5\

BHT-HSV) r anged f rom 0.95 to 1.29 with an average of 1.13
(Table II) .

Rabbits 49. 53 and 63 died during the course of

the experiment; therefore,the data were not included in the
respective g roup data.

The animals in the 5% BHT-HSV group

did not eat at normal levels, lost weight and died .

The

graph in figure 4 illustrates the average daily response

per g roup.

Although overall v i ral infectivity appears lower,

the average daily response peak for the HSV group was at
l east three f o ld

greater than the peak for any group receiving

BHT.
Vi ral Shedding Assays
The eye fluid samples taken for infection of CVI-P cells
in e very case showed a plaque development rate and plaque
morphology consistent to that for HSV-I McKrae strain.

Ob-

served also was an approximate quantitative agreement between
the extent and severity of the eye lesions at the time of
sampling and the amount o f virus recovered.
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Tab l e s Ill. IV a nd V summarize the histor y of each
rabbit t ,h rou g ho ut the cou rs e of its r e s pecti ve expe rime nt.

Inf lammation as evide nced by incre as e d

v~ scul arization

of

the super ficial tissue s of the conjunctiva was observed
in only some of the animals and ge ne rally appeared in
animals infected with hi g her titres of vi rus during period
of g reatest infectivity.

DISCUSSION
Vira

utilization of t he host cell 's machinery f or the

s yn the sis of ne w vi rions limits anti vi ral chemothe rapy due to
the possible ill-effe cts that may be induced in cells.

Most

advances in antiviral chemo therapy involve interference with
viral nucleic acid metabolism by compounds that are structural
analogs to normal precursors of nucleic acid biosynthesis.
These analogs show limited discrimination between host cell
and viral functions and may elicit cytotoxicity, teratogenesis,
mutagenesis and carcinogenesis (Park, et a1., 1978).

Due to

the toxicity and other effects mentioned, new perspectives
must be investigated for viral inactivation.

In the case of

membrane enveloped viruses, studies may involve antiviral
agents that interfere with membrane-associated functions.
The mechanism by which the antiviral effects of BHT are
achieved in vivo remains unknown at the present.

It has been

suggested that its activity is membrane associated.

Being

extremely hydrophobic, BHT localizes almost entirely in the
hydrocarbon phase of membranes and acts as a membrane
perturber modifying the orderly stacking of membrane's alkyl
chains in the lipid bilayer region (Deluca, et al . , 1980).
This perturbanoe may disrupt the continuity of the viral
membrane, preventing viral adsorption to the host cell (Keith,
et al., 1982), or it may alter the protein components of the
viral envelope (Wanda, et al . , 1976).

The small radius of

curvature of the viral membrane, in comparison to the cell
plasma membrane, may be responsible for the greater
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s e nsitivi ty of the vi r al membrane e nvelope (Snipe s and
Keith, 1978).

The observance of the pertu rbance of the viral

membran e by BHT without disrup tion o t the host cell membrane

function has been r epo rted (Deluca, et al., 1980) .

Most

antiviral compounds act either on RNA or DNA viruses.

BHT,

however, has been shown to be an e ffective antiviral a ge nt
against both RNA (Brugh, 1977) and DNA (Snipes, 1975)
enveloped viruses, thereby eluding to the possibilities for
the development of BHT as a broad spectrum antiviral
chemotherapeutic agent.

Past studies show BHT to be

antivirally effective in vitro.
The results of Experiments I and II of this study suggest
that orally administered BRT can be an effective inhibitor
of primary HSV infection in vivo and that the timing of BHT
administration, in relation to viral exposure, is important.
A comparison of the daily response of the three groups
employed i n Experiment I at day five

post-inoculation implies

that BHT is an effective inhibitor of HSV-1 primary infections
at least in the early stages.

However, only two readings

were taken during the course of the first experiment.

The

second reading taken ten days post-inoculation indicated a
subsidence of the infection in the animals inoculated with
HSV not receiving BRT and animals receiving BHT prior to
HSV inoculation .

The group that began receiving BHT two

days post-inoculation showed a higher daily response than
at day five post-inoculation.

Though it appeared that

animals treated with BHT had a lower level of infection
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and that administration of BHT i s most effective prior to
viral exposure, it is apparent from figure 1 that more
readings throughout the course of the experime nts were n eeded
in order to monitor the course of infection.

In Experiment

II , readings were taken at two day intervals starting two
days post-inoculation.

The DR values of all groups were

similar in the early stages; however, from day four, the
level of infection increased at a faster rate for animals
i nfected with HSV not being maintained on a 1 % diet of BHT.
Figure 2 shows the peak of the level of infection at six
days post-inoculation which is consistent with the results
obtained by Kwon and co-workers (1979).

On day six at the

peak in the level of infection, the non-BHT group showed

DR values higher by fourteen-fold than the group that
started receiving BHT treatment prior to infection.

By

day eight the level of infection appeared to decrease in all
groups except the group inoculated with HSV after treatment
of BHT had begun.

The average DR values, however, of this

group were still lower at day eight by a fac tor of two than
the group infected with HSV that did not receive BHT.

The

results of Experiment II appeared consistent with those of
Experiment I which implies that oral admdnistration of BHT
may inhibit the primary infection of HSV in rabbit eyes and
that administration prior to infection may be most effective.
Experiment III, in which the degree of viral exposure
was varied, had readings taken at two day intervals through
day ten post-inoculation.

Consistent with Experiment II, the
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e arly cours e of i n fectio n was sim i lar fo r g rou p s r ece i v in g
BHT an d g roups not r e c ei v i n g Sli T.

Al da y fo ur post- i noc -

ulation the BHT g r oup r e c ei vin g an i noc ul a t i o n of 10 6 pE u
peake d an d thereafte r de c r e a s ed i n i t s l e ve l ot tn ce t i o n.
Th e non- 8 HT g roup i nocul a t e d with 10 6 p f u pe ak ed a t day si x .
The OR val ue s for t he s e t wo g roup s at t h eir r e s pec t i ve
peaks di f fere d by a f actor of th ree wi th the gro u p not

receiving

8HT

show i ng the g r e ater deg r ee o f infection through-

o u t the course of t he e xpe rimen t.
showed t h o s

of

The fi n al DR values

h e n o n - BIIT g r oup t o b e g rea t er

by two- f old at t he fi nal readin g on day ten .

g roups in f ecte d wi th a titre of

lO ~

The two

pfu showed the DR value

f or the non-BHT g roup to b e greater by a factor of three on
d ay e ig ht whe n the level of infection peaked for the non-BHT
g roup.

The g roup receiving BHT showed its highest degree of

i nfection on day t e n post-inoculation.

The two groups

inoculated with the lowest viral titre of 10 2 pfu showed
that, in some cases, orally administered BUT may prevent
p rimary i nfection of HSV in rabbit eyes.

The level of

i nfection of the g roup not receivin g BHT appeared to be
continually increasing at day ten.

The group maintained on

a 0 .5 % diet of BHT and infected with 10 2 pfu showed no
s ign o f infection throu g hout the course of the experiment.
As the viral exposure decreased, the effectiveness of the
BHT treatment in inhibiti n g t he p r i ma r y i n fec ti o n ap pear ed to
increase.

These results indicate

inhibits and in some cases

that a 0 . 5 % diet of BHT

may preve nt primary HSV
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infectio ns in rabb i t e yes depending on the degree of viral
exposure.
All rabbits in Experiment III that d id not r eceive a
d i e t of 0.5 \ BHT died within 14 days post-inoculation.

Many

of these rabbits e xhibited signs of increasing weakness and
fac i al paralysi s until death occurred.

Stevens and Cook

(19 71) r ported that HSV infection elicited paralysis in the
h ind l egs of mice.

Although no pathological studies were

performed in this r e search, it has been reported that severe
HSV i nfections of the cornea may cause viremia and

e ncephalitis (Narang ,

1982; Gangarosa, et al., 1979) and

may have been the cause of death in this experiment.
Six of the ten rabbits inoculated in both eyes showed
an interesting phenomenon in that the IR value of one eye
appeared to be significantly lower than the IR value of
the other eye.

This becomes more interesting when it is

considered that two of the ten rabbits were fed BHT and no
signs of infection were observed for either of their eyes.
It may be possible that the course of infection of one eye
advanced more rapidly triggering the immune system to elicit
a higher antibody titre limiting the observed level of
infection in the second eye.
ve rify this hypothesis.

No studies were performed to

Howeve r, it may merit fur ther

investigation in the future in regard to an attempt to
correlate antibody titre with the time of viral e xpo.ure.
In Experiment IV, in which the

effectivene~8

of var yi ng

dosages of BHT was compared on animals i noc ulated with a
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viral titre of 10 6 pfu, the overall level of infectivity
appeared t o decre ase.

The peak of the level of infection

was observed at 6-8 days post-inoculat : on.

The DR value

of the g roup not r e ceivi ng BHT was g reater by fivefo J d
than a ny of t he grou 5 r ec ivin g BHT.

Th e r an ge o f 0 .001 % to

l ' diets o f BHT appeared to be the most effective dose
range.

The group fed a diet of 5% BHT did not eat at normal

levels and therefore probably did not ingest the 5\ level
of aHT.
unknown.

The actual level of BHT consumed, if any, is
Although the graph in figure IV shows this group

to have the lowest leve l of infectivity, all of the animals
of this group eventually stopped eating and died.
In summary , these experiments answered a sequence of
questions pertaining to the effectiveness of BHT as an
antiviral agent.

First, BHT appears to inhibit primary HSV

infections in rabbit eyes and BHT administration prior to
inoculation is most effective; second,

the effectiveness

of BHT increases as viral exposure decreases .

Finally, the

most e ffective dose range of BHT for treatment of primary
herpes keratitis infection in rabbits was found to be 0.001%
to 1 %.

Along with HSV-1, BHT may be found to be effective
in treatment of HSV-II which has been reported to represent
the major venerea l disease in the United States and has been
strongly correlated to cervical cancer (Rapp, 1978).

Since

the virus persists in latency in the nervous system, the
disease is cumulative in the population; and no treatment
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thus far has b ee n proven t o be complete l y effective as
a cure.

I n ge sted BHT, being stored in the li pid layer o f

the myelin sheath of axons, may e licit a disrup tive effect
on HSV in latency.

Further inve sti gations could involve

the effect of BHT on late nt HSV, HSV infections in other
areas of the body and on other enveloped viruses in vivo.
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